Results 171 to 180 of about 1,032,008 (299)

Strategies and Process of Trade Secret Misappropriation Mitigation: The Case of UK

open access: yesStrategic Change, EarlyView.
ABSTRACT Trade Secrets (TS) are vital for innovation‐driven companies, and their loss can inflict significant financial and reputational damage, particularly in the absence of established policies to mitigate misappropriation in the UK. The current academic literature lacks detailed strategies for firms to effectively address these threats.
Oleksandra Ozcan, David Pickernell
wiley   +1 more source

Mapping the Influence of Ansoff's Corporate Strategy

open access: yesStrategic Change, EarlyView.
ABSTRACT This paper conducts a systematic, data‐driven analysis of H. Igor Ansoff's enduring impact on strategic management scholarship. Despite Ansoff's recognition as the “father of strategic management” and the continued relevance of his frameworks—including the Ansoff matrix, weak signals analysis, and strategic thrust—a comprehensive understanding
Ivan Zupic   +3 more
wiley   +1 more source

CSR disclosure and investment efficiency in MENA countries: The moderating role of CSR committee

open access: yesStrategic Change, EarlyView.
ABSTRACT Corporate social responsibility disclosure (CSRD) is often recognized as a transparency mechanism that allows companies to communicate their commitment to CSR. However, CSRD may also exacerbate agency conflicts. This study addresses these two contrasting perspectives by investigating the impact of CSRD on investment efficiency and exploring ...
Mohamed Malek Belhoula   +3 more
wiley   +1 more source

Elevated quinolizidine alkaloid content in grains of sweet narrow‐leaved lupins when intercropped with oats

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract BACKGROUND Narrow‐leaved lupins (NLL, Lupinus angustifolius L.) is recognized as a climate‐resilient protein crop but its use in food and feed is frequently limited by toxic quinolizidine alkaloids (QAs). The effect of intercropping with spring oat (Avena sativa L.) on grain QA content has not yet been quantified.
Yannik Schlup   +5 more
wiley   +1 more source

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy